Drug development: Allosteric inhibitors hit USP7 hard

January 16th, 2018 by Wei Zhang

Drug development: Allosteric inhibitors hit USP7 hard

Drug development: Allosteric inhibitors hit USP7 hard, Published online: 16 January 2018; doi:10.1038/nchembio.2557

A potent and specific small-molecule inhibitor of a long-sought-after anticancer drug target, USP7, that acts allosterically to inhibit MDM2-stabilizing activity foretells of more allosteric inhibitors for deubiquitinases and E3 ligases.